Journal of Medicinal Chemistry p. 1538 - 1544 (1991)
Update date:2022-09-26
Topics:
Dow
Bechle
Chou
Clark
Hulin
Stevenson
A series of benzyloxazolidine-2,4-diones, containing oxazole-based side chains, were found to lower blood glucose levels in the genetically obese ob/ob mouse. Incorporation of a benzofuran structural element in these compounds provides greatly enhanced in vivo potency. The syntheses and structure-activity relationships for this series are detailed.
View MoreContact:+86-25-52346955
Address:199,JIANYE ROAD,NANJING,CHINA
Shandong Wanda Organosilicon New Material Co., Ltd
Contact:+86-21-54177116;54302881
Address:R1318 Greenland No. 3 Lane 58 Xinjian East Rd., Minhang
Henan Yellow River New Material Technology Co.Ltd.
website:http://www.yellowriverchem.com
Contact:0086-373-7278760
Address:Chengguan Town, Yuanyang County
Changsha Yonta Industry Co., Ltd.
Contact:+ 86-731-8535 2228
Address:Rm.1717, North Bldg., No.368, East 2nd Ring Road(2nd Section)
website:http://www.cheminn.com/
Contact:86-531-67875205
Address:No.9-2,South of Shanda Road, Jinan ,China
Doi:10.1021/ja01591a049
(1956)Doi:10.1016/j.carres.2013.04.008
(2013)Doi:10.1016/0022-328X(91)80081-T
(1991)Doi:10.1021/jm200608k
(2011)Doi:10.1016/j.bmcl.2014.10.031
(2014)Doi:10.1016/j.saa.2011.04.089
(2011)
